A novel nanoconstruct based on poly(lactic-co-glycolic acid) nanoparticles loaded with a tetrathiahelicene molecule conjugated to a fluorescent rhodamine probe was prepared and characterized. Because helicenes are known to be very promising DNA intercalators, the tetrathiahelicene was selected for this study as a model therapeutic cytotoxic molecule. The ability of the nanoconstruct to internalize the tetrathiahelicene and deliver it intracellularly in a safe manner has been investigated by means of cytotoxicity and cell uptake tests on Balb/3T3 clone A31 fibroblasts. The outcomes of this study suggest the suitability of the developed nanoconstruct to act as a vector for the intracellular delivery of hydrophobic small molecules, such as helicenes, thus contributing to their possible future exploitation as novel therapeutics.
A nanostructured PLGA system for cell delivery of a tetrathiahelicene as a model for helical DNA intercalators / S. Cauteruccio, C. Bartoli, C. Carrara, D. Dova, C. Errico, G. Ciampi, D. Dinucci, E. Licandro, F. Chiellini. - In: CHEMPLUSCHEM. - ISSN 2192-6506. - 80:3(2015), pp. 490-493. [10.1002/cplu.201402347]
A nanostructured PLGA system for cell delivery of a tetrathiahelicene as a model for helical DNA intercalators
S. CauteruccioPrimo
;D. Dova;E. LicandroPenultimo
;
2015
Abstract
A novel nanoconstruct based on poly(lactic-co-glycolic acid) nanoparticles loaded with a tetrathiahelicene molecule conjugated to a fluorescent rhodamine probe was prepared and characterized. Because helicenes are known to be very promising DNA intercalators, the tetrathiahelicene was selected for this study as a model therapeutic cytotoxic molecule. The ability of the nanoconstruct to internalize the tetrathiahelicene and deliver it intracellularly in a safe manner has been investigated by means of cytotoxicity and cell uptake tests on Balb/3T3 clone A31 fibroblasts. The outcomes of this study suggest the suitability of the developed nanoconstruct to act as a vector for the intracellular delivery of hydrophobic small molecules, such as helicenes, thus contributing to their possible future exploitation as novel therapeutics.File | Dimensione | Formato | |
---|---|---|---|
cplu.201402347.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.37 MB
Formato
Adobe PDF
|
1.37 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.